Lobbying related to Congressional and Administration introductions and company updates, communications related to company operations and CRDMO industry, including descriptions of corporate structure, business units, and data handling.
2025 · 4th Quarter (Oct 1 - Dec 31)
WUXI BIOLOGICS USA LLC
Filed by WUXI BIOLOGICS USA LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- Not reported
- Expenses
- $110,000.00
- Registrant
- WUXI BIOLOGICS USA LLC
- Client
- WUXI BIOLOGICS USA LLC
- Filing UUID
- fd3d5f8e-3ff8-48f0-a884-3c5dfafc074d
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.